MUZAFFAR H QAZILBASH to Neoplasms
This is a "connection" page, showing publications MUZAFFAR H QAZILBASH has written about Neoplasms.
Connection Strength
0.071
-
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial. Nat Med. 2024 Mar; 30(3):772-784.
Score: 0.036
-
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2023 05 23; 7(10):2000-2003.
Score: 0.035